Sandbox: Syncope: Difference between revisions

Jump to navigation Jump to search
Line 16: Line 16:
| bgcolor="LemonChiffon" | IIb || bgcolor="LightBlue" | B-NR || Use of risk stratification scores may be reasonable in the management of patients with syncope.  
| bgcolor="LemonChiffon" | IIb || bgcolor="LightBlue" | B-NR || Use of risk stratification scores may be reasonable in the management of patients with syncope.  
|-  
|-  
| Recommendations for Disposition After Initial Evaluation. || ||
| colspan="3" | '''Recommendations for Disposition After Initial Evaluation'''
|-  
|-  
| bgcolor="LightGreen" | I || bgcolor="LightBlue" | B-NR || Hospital evaluation and treatment are recommended for patients presenting with syncope who have a serious medical condition potentially relevant to the cause of syncope identified during initial evaluation.
| bgcolor="LightGreen" | I || bgcolor="LightBlue" | B-NR || Hospital evaluation and treatment are recommended for patients presenting with syncope who have a serious medical condition potentially relevant to the cause of syncope identified during initial evaluation.
Line 26: Line 26:
| bgcolor="LemonChiffon" | IIb || bgcolor="LightBlue" | C-LD || It may be reasonable to manage selected patients with suspected cardiac syncope in the outpatient setting in the absence of serious medical conditions.
| bgcolor="LemonChiffon" | IIb || bgcolor="LightBlue" | C-LD || It may be reasonable to manage selected patients with suspected cardiac syncope in the outpatient setting in the absence of serious medical conditions.
|-  
|-  
| Recommendations for Blood Testing || ||
| colspan="3" | '''Recommendations for Blood Testing'''
|-  
|-  
| bgcolor="LemonChiffon" | IIa || bgcolor="LightBlue" | B-NR || Targeted blood tests are reasonable in the evaluation of selected patients with syncope identified on the basis of clinical assessment from history, physical examination, and ECG.  
| bgcolor="LemonChiffon" | IIa || bgcolor="LightBlue" | B-NR || Targeted blood tests are reasonable in the evaluation of selected patients with syncope identified on the basis of clinical assessment from history, physical examination, and ECG.  
Line 33: Line 33:
|-  
|-  
| bgcolor="LightCoral" | III No Benefit || bgcolor="LightBlue" | B-NR || Targeted blood tests are reasonable in the evaluation of selected patients with syncope identified on the basis of clinical assessment from history, physical examination, and ECG.
| bgcolor="LightCoral" | III No Benefit || bgcolor="LightBlue" | B-NR || Targeted blood tests are reasonable in the evaluation of selected patients with syncope identified on the basis of clinical assessment from history, physical examination, and ECG.
|}

Revision as of 00:27, 30 October 2017

2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope

Recommendation for History and Physical Examination

COR LOE RECOMMENDATION
I B-NR A detailed history and physical examination should be performed in patients with syncope.
I B-NR In the initial evaluation of patients with syncope, a resting 12-lead electrocardiogram (ECG) is useful.
I B-NR Evaluation of the cause and assessment for the short- and long-term morbidity and mortality risk of syncope are recommended.
IIb B-NR Use of risk stratification scores may be reasonable in the management of patients with syncope.
Recommendations for Disposition After Initial Evaluation
I B-NR Hospital evaluation and treatment are recommended for patients presenting with syncope who have a serious medical condition potentially relevant to the cause of syncope identified during initial evaluation.
IIa C-LD It is reasonable to manage patients with presumptive reflex-mediated syncope in the outpatient setting in the absence of serious medical conditions.
IIa B-R In intermediate-risk patients with an unclear cause of syncope, use of a structured ED observation protocol can be effective in reducing hospital admission.
IIb C-LD It may be reasonable to manage selected patients with suspected cardiac syncope in the outpatient setting in the absence of serious medical conditions.
Recommendations for Blood Testing
IIa B-NR Targeted blood tests are reasonable in the evaluation of selected patients with syncope identified on the basis of clinical assessment from history, physical examination, and ECG.
IIb C-LD Usefulness of brain natriuretic peptide and high-sensitivity troponin measurement is uncertain in patients for whom a cardiac cause of syncope is suspected.
III No Benefit B-NR Targeted blood tests are reasonable in the evaluation of selected patients with syncope identified on the basis of clinical assessment from history, physical examination, and ECG.